A large proportion of ICU-acquired infections are related to multidrug-resistant bacteria
(MDR). Infections caused by these bacteria are associated with increased mortality, and …

The relationship between exposure to air pollution and the severity of coronavirus disease
2019 (COVID-19) pneumonia and other outcomes is poorly understood. Beyond age and …

Introduction: Ventilator-associated pneumonia (VAP) incidence is high among critically ill
COVID-19 patients. Its attributable mortality remains underestimated, especially for …

Many meta-analyses have assessed the efficacy of preventive interventions against
ventilator-associated pneumonia (VAP) in critically ill patients. However, there has been no …

Objectives To compare the occurrence of healthcare-associated infections acquired in
intensive care units (HAI-ICUs) in France among patients with COVID-19 and those without it …

Background Data on ventilator associated pneumonia (VAP) in COVID-19 and influenza
patients admitted to intensive care units (ICU) are scarce. This study aimed to estimate day …

Introduction Ventilator‐associated pneumonia (VAP) is a hospital‐acquired infection with
high mortality, and remains a challenge for clinical treatment. Red blood cell distribution …

The SARS-CoV-2 infection is a cause of hypoxemic acute respiratory failure, leading to
frequent intensive care unit (ICU) admission. Due to invasive organ support and …

Shortly after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), cases of viral, bacterial, and fungal coinfections in hospitalized patients became evident …

Background: There is limited data on ventilator-associated pneumonia (VAP) and multidrug-
resistant VAP (MDR VAP) among COVID-19 patients. Methods: A retrospective study in a …